2022
Temporal trends and long-term outcomes among recipients of cardiac resynchronization therapy with defibrillator in the United States, 2011–2015: Insights from the National Cardiovascular Data Registry
Darden D, Peterson PN, Xin X, Munir MB, Minges KE, Goldenberg I, Poole JE, Feld GK, Birgersdotter-Green U, Curtis JP, Hsu JC. Temporal trends and long-term outcomes among recipients of cardiac resynchronization therapy with defibrillator in the United States, 2011–2015: Insights from the National Cardiovascular Data Registry. Heart Rhythm O2 2022, 3: 405-414. PMID: 36097450, PMCID: PMC9463686, DOI: 10.1016/j.hroo.2022.03.004.Peer-Reviewed Original ResearchLong-term outcomesGuideline-concordant recommendationsHeart failure hospitalizationCardiac resynchronization therapyFailure hospitalizationCause hospitalizationCardiovascular hospitalizationResynchronization therapyNational Cardiovascular Data RegistryCRT-D implantationYear of implantHospital procedural complicationsHospital complicationsHospital outcomesMultivariable adjustmentPatient characteristicsProcedural complicationsDefibrillator recipientsHospitalizationData registryLower riskMedicare beneficiariesMedicare dataOutcomesRecipients
2021
Use and Outcomes of Dual Chamber or Cardiac Resynchronization Therapy Defibrillators Among Older Patients Requiring Ventricular Pacing in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry
Borne RT, Masoudi FA, Curtis JP, Zipse MM, Sandhu A, Hsu JC, Peterson PN. Use and Outcomes of Dual Chamber or Cardiac Resynchronization Therapy Defibrillators Among Older Patients Requiring Ventricular Pacing in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry. JAMA Network Open 2021, 4: e2035470. PMID: 33496796, PMCID: PMC7838925, DOI: 10.1001/jamanetworkopen.2020.35470.Peer-Reviewed Original ResearchConceptsCardiac resynchronization therapyHeart failure hospitalizationClass I indicationsUse of CRTFailure hospitalizationMedian odds ratioCohort studyOlder patientsVentricular pacingImplant ratesNational Cardiovascular Data Registry Implantable Cardioverter Defibrillator RegistryNational Cardiovascular Data Registry ICD RegistryReduced left ventricular ejection fractionMultivariable Cox proportional hazards modelsFrequent right ventricular pacingImplantable Cardioverter-Defibrillator RegistryPrior heart failure hospitalizationLeft ventricular ejection fractionImplantable cardioverter defibrillator implantationThird-degree atrioventricular blockCardiac resynchronization therapy defibrillatorCox proportional hazards modelBradycardia pacing indicationFirst-time implantationFrequent RV pacing
2020
Comparison of left ventricular lead upgrade vs continued medical care among patients eligible for cardiac resynchronization therapy at the time of defibrillator generator replacement: Predictors of left ventricular lead upgrade and associations with long-term outcomes
Hyman MC, Bao H, Curtis JP, Minges K, Schaller RD, Birgersdotter-Green U, Marchlinski FE, Hsu JC. Comparison of left ventricular lead upgrade vs continued medical care among patients eligible for cardiac resynchronization therapy at the time of defibrillator generator replacement: Predictors of left ventricular lead upgrade and associations with long-term outcomes. Heart Rhythm 2020, 17: 1878-1886. PMID: 32497762, DOI: 10.1016/j.hrthm.2020.05.032.Peer-Reviewed Original ResearchConceptsCardiac resynchronization therapyCRT-eligible patientsCRT upgradeResynchronization therapyClinical outcomesNational Cardiovascular Data Registry ICD RegistryGenerator replacementPeriprocedural complication rateLeft ventricular leadSubpopulation of patientsLong-term outcomesICD generator replacementHierarchical logistic regression modelsLogistic regression modelsSecondary endpointsCause mortalityPrimary endpointComplication rateICD RegistryProcedural complicationsMedical managementICD populationNational registryVentricular leadClaims data
2019
Body mass index and outcomes of cardiac resynchronization with implantable cardioverter‐defibrillator therapy in older patients with heart failure
Echouffo‐Tcheugui J, Masoudi FA, Bao H, Curtis JP, Heidenreich PA, Fonarow GC. Body mass index and outcomes of cardiac resynchronization with implantable cardioverter‐defibrillator therapy in older patients with heart failure. European Journal Of Heart Failure 2019, 21: 1093-1102. PMID: 31359595, DOI: 10.1002/ejhf.1552.Peer-Reviewed Original ResearchConceptsBody mass indexDevice-related complicationsNormal weightMass indexNational Cardiovascular Data Registry Implantable Cardioverter Defibrillator RegistryImplantable Cardioverter-Defibrillator RegistryImplantable cardioverter-defibrillator therapyClass III obesityHeart failure outcomesCardioverter-defibrillator therapyObesity class IObesity class IICardiac resynchronization therapyObesity class IIIHF patientsUnderweight patientsDefibrillator implantationElderly patientsHazard ratioObese patientsOlder patientsBMI categoriesHeart failureResynchronization therapyCardiac resynchronizationQuadripolar versus bipolar leads in cardiac resynchronization therapy: An analysis of the National Cardiovascular Data Registry
Hakemi EU, Doukky R, Parzynski CS, Curtis JP, Madias C. Quadripolar versus bipolar leads in cardiac resynchronization therapy: An analysis of the National Cardiovascular Data Registry. Heart Rhythm 2019, 17: 81-89. PMID: 31369870, DOI: 10.1016/j.hrthm.2019.07.028.Peer-Reviewed Original ResearchConceptsCardiac resynchronization therapyNational Cardiovascular Data RegistryClinical outcomesResynchronization therapyData registryLong-term clinical outcomesStimulation rateSignificant differencesCongestive heart failure admissionsMedicaid ServicesCRT device implantsHeart failure admissionsProcedural complication rateCRT implantationElderly patientsComplication ratePrimary outcomePlacement failureDevice implantsDevice malfunctionOutcomesPatientsBipolar leadsRegistryTherapyCardiac Resynchronization Defibrillator Therapy for Nonspecific Intraventricular Conduction Delay Versus Right Bundle Branch Block
Kawata H, Bao H, Curtis JP, Minges KE, Mitiku T, Birgersdotter-Green U, Feld GK, Hsu JC. Cardiac Resynchronization Defibrillator Therapy for Nonspecific Intraventricular Conduction Delay Versus Right Bundle Branch Block. Journal Of The American College Of Cardiology 2019, 73: 3082-3099. PMID: 31221257, DOI: 10.1016/j.jacc.2019.04.025.Peer-Reviewed Original ResearchConceptsNonspecific intraventricular conduction delayRight bundle branch blockCardiac resynchronization therapyCRT-D implantationCRT-eligible patientsBundle branch blockQRS durationHazard ratioBranch blockBetter outcomesCardiac resynchronization defibrillator therapyMultivariable adjusted hazard ratiosAdjusted hazard ratioIntraventricular conduction delayCareful patient selectionEligible patientsDefibrillator therapyMultivariable adjustmentResynchronization therapyClinical outcomesPatient selectionConduction abnormalitiesRegistry dataConduction delayPatients
2017
Coronary Venous Dissection from Left Ventricular Lead Placement During Cardiac Resynchronization Therapy With Defibrillator Implantation and Associated in-Hospital Adverse Events (from the NCDR ICD Registry)
Hsu JC, Varosy PD, Bao H, Dewland TA, Curtis JP, Marcus GM. Coronary Venous Dissection from Left Ventricular Lead Placement During Cardiac Resynchronization Therapy With Defibrillator Implantation and Associated in-Hospital Adverse Events (from the NCDR ICD Registry). The American Journal Of Cardiology 2017, 121: 55-61. PMID: 29102348, DOI: 10.1016/j.amjcard.2017.09.019.Peer-Reviewed Original ResearchConceptsCRT-D recipientsVentricular lead placementHospital adverse eventsVenous dissectionMultivariable adjustmentAdverse eventsMajor complicationsLead placementGreater oddsPrevious coronary artery bypass graftImplantable Cardioverter-Defibrillator RegistryLeft ventricular lead placementCoronary artery bypass graftHierarchical multivariable logistic regressionHospital clinical outcomesArtery bypass graftCardiac resynchronization therapyMultivariable logistic regressionBundle branch blockHospital complicationsHospital mortalityHospital deathHospital stayDefibrillator implantationProlonged hospitalizationUse of Cardiac Resynchronization Therapy Among Eligible Patients Receiving an Implantable Cardioverter Defibrillator: Insights From the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry
Marzec LN, Peterson PN, Bao H, Curtis JP, Masoudi FA, Varosy PD, Bradley SM. Use of Cardiac Resynchronization Therapy Among Eligible Patients Receiving an Implantable Cardioverter Defibrillator: Insights From the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry. JAMA Cardiology 2017, 2: 561-565. PMID: 28122073, PMCID: PMC5814986, DOI: 10.1001/jamacardio.2016.5388.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overAtrial FibrillationBlack or African AmericanBundle-Branch BlockCardiac Resynchronization TherapyCardiac Resynchronization Therapy DevicesCerebrovascular DisordersCohort StudiesComorbidityDefibrillators, ImplantableDiabetes MellitusEthnicityFemaleHealth Facility SizeHeart FailureHospitalsHospitals, TeachingHumansHypertensionInsurance, HealthLung DiseasesMaleMedicaidMedicareMiddle AgedMortalityMyocardial IschemiaPractice Patterns, Physicians'RegistriesRegression AnalysisRetrospective StudiesUnited StatesWhite PeopleConceptsUse of CRTCardiac resynchronization therapyCRT-D useImplantable cardioverter defibrillatorGuideline-eligible patientsDevice implantationEligible patientsResynchronization therapyCardioverter defibrillatorNational Cardiovascular Data Registry Implantable Cardioverter Defibrillator RegistryNational Cardiovascular Data Registry ICD RegistryHeart failure-related eventsImplantable Cardioverter-Defibrillator RegistryCRT-D groupMulticenter retrospective cohortRisk-standardized ratesHospital-level variationCRT-D devicesHierarchical multivariable modelNonprivate insuranceRetrospective cohortSelect patientsICD RegistryGuideline recommendationsICD placementAddition of Blood Pressure and Weight Transmissions to Standard Remote Monitoring of Implantable Defibrillators and its Association with Mortality and Rehospitalization
Al-Chekakie MO, Bao H, Jones PW, Stein KM, Marzec L, Varosy PD, Masoudi FA, Curtis JP, Akar JG. Addition of Blood Pressure and Weight Transmissions to Standard Remote Monitoring of Implantable Defibrillators and its Association with Mortality and Rehospitalization. Circulation Cardiovascular Quality And Outcomes 2017, 10: e003087. PMID: 28506978, DOI: 10.1161/circoutcomes.116.003087.Peer-Reviewed Original ResearchConceptsBlood pressure dataImplantable defibrillatorsRemote patient monitoringTransmission of weightHeart failure hospitalizationImpaired ejection fractionCardiac resynchronization therapyCox regression modelRisk of mortalityLogistic regression modelsRoutine weightCause hospitalizationFailure hospitalizationBlood pressureCardiovascular hospitalizationEjection fractionResynchronization therapyRegression modelsDevice implantationService patientsHospital characteristicsIndependent associationImproved outcomesLandmark analysisSimilar riskQUADRIPOLAR VERSUS BIPOLAR LEFT VENTRICULAR LEADS IN CARDIAC RESYNCHRONIZATION THERAPY: AN ANALYSIS FROM THE NCDR
Hakemi E, Doukky R, Parzynski C, Curtis J, Madias C. QUADRIPOLAR VERSUS BIPOLAR LEFT VENTRICULAR LEADS IN CARDIAC RESYNCHRONIZATION THERAPY: AN ANALYSIS FROM THE NCDR. Journal Of The American College Of Cardiology 2017, 69: 335. DOI: 10.1016/s0735-1097(17)33724-5.Peer-Reviewed Original Research
2016
Association Between a Prolonged PR Interval and Outcomes of Cardiac Resynchronization Therapy
Friedman DJ, Bao H, Spatz ES, Curtis JP, Daubert JP, Al-Khatib SM. Association Between a Prolonged PR Interval and Outcomes of Cardiac Resynchronization Therapy. Circulation 2016, 134: 1617-1628. PMID: 27760795, PMCID: PMC5418126, DOI: 10.1161/circulationaha.116.022913.Peer-Reviewed Original ResearchConceptsHeart failure hospitalizationFailure hospitalizationPR intervalImplantable cardioverter defibrillatorNational Cardiovascular Data Registry ICD RegistryCardiac resynchronization therapy candidatesIncident heart failure hospitalizationReal-world comparative effectivenessCRT-eligible patientsReceipt of CRTChronic kidney diseaseCardiac resynchronization therapyCRT-D patientsCoronary artery diseaseProlonged PR intervalComparative effectiveness analysisMore comorbiditiesArtery diseaseDiabetes mellitusICD recipientsICD RegistryResynchronization therapyAtrial arrhythmiasKidney diseaseCardioverter defibrillator
2015
Comparative Effectiveness of CRT-D Versus Defibrillator Alone in HF Patients With Moderate-to-Severe Chronic Kidney Disease
Friedman DJ, Singh JP, Curtis JP, Tang WHW, Bao H, Spatz ES, Hernandez AF, Patel UD, Al-Khatib SM. Comparative Effectiveness of CRT-D Versus Defibrillator Alone in HF Patients With Moderate-to-Severe Chronic Kidney Disease. Journal Of The American College Of Cardiology 2015, 66: 2618-2629. PMID: 26670062, DOI: 10.1016/j.jacc.2015.09.097.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overCardiac Resynchronization TherapyComorbidityComparative Effectiveness ResearchDefibrillators, ImplantableElectric CountershockFemaleGlomerular Filtration RateHeart FailureHospitalizationHumansMaleMedicareProportional Hazards ModelsRenal Insufficiency, ChronicSeverity of Illness IndexSurvival AnalysisTreatment OutcomeUnited StatesConceptsSevere chronic kidney diseaseChronic kidney diseaseCardiac resynchronization therapyCRT-eligible patientsHF hospitalizationKidney diseaseNational Cardiovascular Data Registry ICD RegistryUse of CRTComparative effectivenessInverse probability-weighted analysisReal-world comparative effectivenessEnd-stage renal diseaseCox proportional hazards modelCRT-D useHeart failure hospitalizationAcceptable complication rateDevice-related complicationsProportional hazards modelFine-Gray modelCKD classCKD stageFailure hospitalizationHF patientsPrimary endpointSecondary endpointsDoes Age Influence Cardiac Resynchronization Therapy Use and Outcome?
Heidenreich PA, Tsai V, Bao H, Curtis J, Goldstein M, Curtis L, Hernandez A, Peterson P, Turakhia MP, Masoudi FA. Does Age Influence Cardiac Resynchronization Therapy Use and Outcome? JACC Heart Failure 2015, 3: 497-504. PMID: 25982109, DOI: 10.1016/j.jchf.2015.01.012.Peer-Reviewed Original ResearchConceptsLeft ventricular ejection fractionICD implantationOlder patientsTrial criteriaNew York Heart Association functional class IIIAge groupsSocial Security Death IndexPatients age 85Receipt of CRTFunctional class IIICardiac resynchronization therapyVentricular ejection fractionClinical trial criteriaDifferent age groupsPatient ageEjection fractionICD RegistryImproved survivalPrimary outcomeResynchronization therapyTherapy useDeath IndexMean ageClinical trialsRegistry dataCOMPARATIVE EFFECTIVENESS OF CARDIAC RESYNCHRONIZATION THERAPY WITH DEFIBRILLATOR VERSUS DEFIBRILLATOR ALONE IN HEART FAILURE PATIENTS WITH MODERATE TO SEVERE CHRONIC KIDNEY DISEASE
Friedman D, Singh J, Curtis J, Tang W, Bao H, Spatz E, Hernandez A, Patel U, Al-Khatib S. COMPARATIVE EFFECTIVENESS OF CARDIAC RESYNCHRONIZATION THERAPY WITH DEFIBRILLATOR VERSUS DEFIBRILLATOR ALONE IN HEART FAILURE PATIENTS WITH MODERATE TO SEVERE CHRONIC KIDNEY DISEASE. Journal Of The American College Of Cardiology 2015, 65: a452. DOI: 10.1016/s0735-1097(15)60452-1.Peer-Reviewed Original ResearchCardiac resynchronization therapyResynchronization therapyKidney diseaseComparative effectivenessPatientsTherapyDefibrillatorDiseaseCardiac Resynchronization Therapy in Women Versus Men
Zusterzeel R, Spatz ES, Curtis JP, Sanders WE, Selzman KA, Piña IL, Bao H, Ponirakis A, Varosy PD, Masoudi FA, Caños DA, Strauss DG. Cardiac Resynchronization Therapy in Women Versus Men. Circulation Cardiovascular Quality And Outcomes 2015, 8: s4-s11. PMID: 25714821, DOI: 10.1161/circoutcomes.114.001548.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overBundle-Branch BlockCardiac Resynchronization TherapyCardiac Resynchronization Therapy DevicesDefibrillators, ImplantableElectric CountershockFemaleHealth Status DisparitiesHeart Conduction SystemHeart FailureHumansKaplan-Meier EstimateMalePropensity ScoreProportional Hazards ModelsRegistriesRisk FactorsSex FactorsStroke VolumeTreatment OutcomeUnited StatesVentricular Function, LeftConceptsLeft bundle branch blockQRS durationImplantable cardioverter defibrillatorPatient sexDeath riskCardioverter defibrillatorBetter survivalMortality differencesNew York Heart Association class IIILeft ventricular ejection fractionWomen Versus MenCardiac resynchronization therapyVentricular ejection fractionRelative death riskBenefit of CRTLonger QRS durationShorter QRS durationBundle branch blockLower mortality riskEjection fractionHeart failureResynchronization therapyCardiac resynchronizationBranch blockMortality risk
2014
Clinical Effectiveness of Cardiac Resynchronization Therapy Versus Medical Therapy Alone Among Patients With Heart Failure
Khazanie P, Hammill BG, Qualls LG, Fonarow GC, Hammill SC, Heidenreich PA, Al-Khatib SM, Piccini JP, Masoudi FA, Peterson PN, Curtis JP, Hernandez AF, Curtis LH. Clinical Effectiveness of Cardiac Resynchronization Therapy Versus Medical Therapy Alone Among Patients With Heart Failure. Circulation Heart Failure 2014, 7: 926-934. PMID: 25227768, PMCID: PMC4244212, DOI: 10.1161/circheartfailure.113.000838.Peer-Reviewed Original ResearchConceptsAcute Decompensated Heart Failure National RegistryImplantable Cardioverter-Defibrillator RegistryHeart failureMedical therapyCardiovascular readmissionCause readmissionQRS durationNational Cardiovascular Data Registry Implantable Cardioverter Defibrillator RegistryLeft ventricular ejection fractionCox proportional hazards modelHistorical control cohortOptimal medical therapyCardiac resynchronization therapyVentricular ejection fractionProportional hazards modelMultivariable adjustmentEjection fractionICD RegistryResynchronization therapyClinical effectivenessControl cohortNational registryClinical trialsLower riskHazards modelTemporal Trends in Patient Characteristics and Outcomes Among Medicare Beneficiaries Undergoing Primary Prevention Implantable Cardioverter-Defibrillator Placement in the United States, 2006–2010
Borne RT, Peterson PN, Greenlee R, Heidenreich PA, Wang Y, Curtis JP, Tzou WS, Varosy PD, Kremers MS, Masoudi FA. Temporal Trends in Patient Characteristics and Outcomes Among Medicare Beneficiaries Undergoing Primary Prevention Implantable Cardioverter-Defibrillator Placement in the United States, 2006–2010. Circulation 2014, 130: 845-853. PMID: 25095884, DOI: 10.1161/circulationaha.114.008653.Peer-Reviewed Original ResearchConceptsPrimary prevention ICD implantationDevice-related complicationsPatient characteristicsICD implantationICD RegistryNational Cardiovascular Data Registry ICD RegistryPrimary prevention implantable cardioverter-defibrillator placementConcomitant cardiac resynchronization therapyLeft ventricular ejection fractionImplantable cardioverter-defibrillator placementMultivariable hierarchical logistic regressionCardiac resynchronization therapy devicesCardiac resynchronization therapyVentricular ejection fractionResynchronization therapy devicesCommunity practice settingsSingle-lead deviceHierarchical logistic regressionClinical characteristicsOlder patientsEjection fractionResynchronization therapyPrimary preventionPatient populationHospital characteristicsComparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study.
Masoudi FA, Mi X, Curtis LH, Peterson PN, Curtis JP, Fonarow GC, Hammill SC, Heidenreich PA, Al-Khatib SM, Piccini JP, Qualls LG, Hernandez AF. Comparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study. Annals Of Internal Medicine 2014, 160: 603-11. PMID: 24798523, DOI: 10.7326/m13-1879.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overCardiac Resynchronization TherapyComparative Effectiveness ResearchDefibrillators, ImplantableElectrocardiographyHeart FailureHumansInfectionsPatient ReadmissionPropensity ScoreRetrospective StudiesRisk FactorsStroke VolumeTreatment OutcomeVentricular Dysfunction, LeftConceptsReduced left ventricular ejection fractionLeft ventricular ejection fractionHeart failure readmissionVentricular ejection fractionCardiac resynchronization therapyICD therapyQRS durationLower riskCohort studyICD RegistryResynchronization therapyEjection fractionNational Cardiovascular Data Registry ICD RegistryImplantable cardioverter-defibrillator therapyLeft bundle branch blockPropensity-matched patientsRetrospective cohort studyCardioverter-defibrillator therapyDevice-related complicationsBundle branch blockDevice-related infectionsCardiovascular readmissionCause readmissionDefibrillator therapyICD implantationPrevalence of Guideline-Directed Medical Therapy Among Patients Receiving Cardiac Resynchronization Therapy Defibrillator Implantation in the National Cardiovascular Data Registry During the Years 2006 to 2008
Schneider PM, Pellegrini CN, Wang Y, Fein AS, Reynolds MR, Curtis JP, Masoudi FA, Varosy PD. Prevalence of Guideline-Directed Medical Therapy Among Patients Receiving Cardiac Resynchronization Therapy Defibrillator Implantation in the National Cardiovascular Data Registry During the Years 2006 to 2008. The American Journal Of Cardiology 2014, 113: 2052-2056. PMID: 24793671, PMCID: PMC4346333, DOI: 10.1016/j.amjcard.2014.03.049.Peer-Reviewed Original ResearchMeSH KeywordsAdrenergic beta-AntagonistsAged, 80 and overAngiotensin-Converting Enzyme InhibitorsCardiac Resynchronization TherapyCombined Modality TherapyDeath, Sudden, CardiacDefibrillators, ImplantableFemaleFollow-Up StudiesHeart FailureHumansMaleMiddle AgedPractice Guidelines as TopicPrevalenceRegistriesRetrospective StudiesRisk AssessmentSurvival AnalysisTreatment OutcomeUnited StatesVentricular Dysfunction, LeftConceptsGuideline-directed medical therapyCardiac resynchronization therapyImplantable Cardioverter-Defibrillator RegistryAngiotensin II receptor inhibitorΒ-blockersMedical therapyClass IReceptor inhibitorsNational Cardiovascular Data Registry Implantable Cardioverter Defibrillator RegistryCardiac resynchronization therapy defibrillator implantationLeft ventricular systolic dysfunctionSevere heart failure symptomsAngiotensin-converting enzyme inhibitorNational Cardiovascular Data RegistryClass I indicationsCRT-D implantationHeart failure symptomsVentricular systolic dysfunctionProportion of patientsSelection of patientsReal-world patientsAngiotensin-converting enzymePrevalence of guidelinesContemporaneous guidelinesQuality improvement targetsSEX-SPECIFIC MORTALITY RISK BY QRS MORPHOLOGY AND DURATION IN PATIENTS RECEIVING CARDIAC RESYNCHRONIZATION THERAPY: RESULTS FROM THE NCDR®
Zusterzeel R, Curtis J, Canos D, Sanders W, Selzman K, Pina I, Spatz E, Bao H, Ponirakis A, Varosy P, Masoudi F, Strauss D. SEX-SPECIFIC MORTALITY RISK BY QRS MORPHOLOGY AND DURATION IN PATIENTS RECEIVING CARDIAC RESYNCHRONIZATION THERAPY: RESULTS FROM THE NCDR®. Journal Of The American College Of Cardiology 2014, 63: a719. DOI: 10.1016/s0735-1097(14)60719-1.Peer-Reviewed Original ResearchSex-specific mortality risksCardiac resynchronization therapyResynchronization therapyMortality riskQRS morphologyPatientsNCDRTherapy